AceLink is advancing a small-molecule treatment option for Fabry disease, which could provide a more convenient alternative ...
In summary, enalapril significantly mitigated multiple pathological markers associated with aging, including lipid droplets, amyloid, glycogen deposition, and fibrosis, in the brain, kidneys, liver, ...
AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim d ...
angiotensin-converting enzyme (ACE) inhibitors and angiotensin-II-receptor-blocking drugs. These are potential 'second line' drugs. 1.1 MO Recurrent headache disorder manifesting in attacks ...
Given the success of the previous Research Topic 'Exploring Small Molecule Inhibitors in Cardiovascular and Cerebrovascular Diseases', we are pleased to ...
Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...
Cough and angioedema are well-known adverse reactions of ACE inhibitors. However, other adverse effects of upper airways such as postnasal drainage, rhinitis and nasal blockage, are less frequently ...
The pathogenesis of AIA has implicated both the lipoxygenase (LO) and the cyclooxygenase (COX) pathways. By inhibiting the COX pathway, aspirin diverts arachidonic acid metabolites to the LO pathway.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback